Substituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements

Substituted 1,6-naphthyridine derivatives, a new class of human cytomegalovirus inhibitors, were prepared to demonstrate the role of intramolecular hydrogen bonds to maintain the compounds in their active conformation.